×
About 5,175 results

ALLMedicine™ Valvular Heart Disease Center

Research & Reviews  1,496 results

Temporal change in repolarization parameters after surgical correction of valvular hear...
https://doi.org/10.1016/j.jelectrocard.2023.02.004
Journal of Electrocardiology; Cho MS, Seo HC et. al.

Mar 20th, 2023 - Ventricular tachyarrhythmia is a potentially fatal outcome of cardiac surgery. Abrupt changes in the hemodynamics after surgical correction of valvular heart disease (VHD) can lead to alterations in ventricular repolarization. We compared the diff...

Identification of Potent, Selective, and Peripherally Restricted Serotonin Receptor 2B ...
https://doi.org/10.1089/adt.2022.116
Assay and Drug Development Technologies; Bender AM, Valentine MS et. al.

Mar 18th, 2023 - Antagonists of the serotonin receptor 2B (5-HT2B) have shown great promise as therapeutics for the treatment of pulmonary arterial hypertension, valvular heart disease, and related cardiopathies. Herein, we describe a high-throughput screen campai...

Unmet needs in valvular heart disease.
https://doi.org/10.1093/eurheartj/ehad121
European Heart Journal; Messika-Zeitoun D, Baumgartner H et. al.

Mar 17th, 2023 - Valvular heart disease (VHD) is the next epidemic in the cardiovascular field, affecting millions of people worldwide and having a major impact on health care systems. With aging of the population, the incidence and prevalence of VHD will continue...

Designing Biocompatible Tissue Engineered Heart Valves In Situ: JACC Review Topic of th...
https://doi.org/10.1016/j.jacc.2022.12.022
Journal of the American College of Cardiology; Cordoves EM, Vunjak-Novakovic G et. al.

Mar 9th, 2023 - Valvular heart disease is a globally prevalent cause of morbidity and mortality, with both congenital and acquired clinical presentations. Tissue engineered heart valves (TEHVs) have the potential to radically shift the treatment landscape for val...

Correlation between frailty and cardiac structure and function in echocardiography in e...
https://doi.org/10.1007/s40520-023-02363-5
Aging Clinical and Experimental Research; Xi L, Xuemei Z et. al.

Mar 5th, 2023 - This study aims to accurately evaluate the cardiac structure and function of the frail population in elderly patients with normal ejection fraction (EF) using the 3D volume quantification and speckle tracking of echocardiography, to explore the co...

see more →

Guidelines  20 results

ACR Appropriateness Criteria® Dyspnea-Suspected Cardiac Origin (Ischemia Already Exclud...
https://doi.org/10.1016/j.jacr.2022.02.014
Journal of the American College of Radiology : JACR; , Bolen MA et. al.

May 14th, 2022 - Dyspnea is the symptom of perceived breathing discomfort and is commonly encountered in a variety of clinical settings. Cardiac etiologies of dyspnea are an important consideration; among these, valvular heart disease (Variant 1), arrhythmia (Vari...

2020 ACC/AHA guideline for the management of patients with valvular heart disease: A re...
https://doi.org/10.1016/j.jtcvs.2021.04.002
The Journal of Thoracic and Cardiovascular Surgery; , Otto CM et. al.

May 12th, 2021 - 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2021| ,Otto CM,Nishimura RA,Bonow RO,Cara...

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Exec...
https://doi.org/10.1016/j.jacc.2020.11.035
Journal of the American College of Cardiology; , Otto CM et. al.

Dec 22nd, 2020 - This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. A comprehensive literature search was ...

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Exec...
https://doi.org/10.1161/CIR.0000000000000932
Circulation Otto CM, Nishimura RA et. al.

Dec 18th, 2020 - This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. A comprehensive literature search was ...

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Re...
https://doi.org/10.1161/CIR.0000000000000923
Circulation Otto CM, Nishimura RA et. al.

Dec 18th, 2020 - 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2020|Otto CM,Nishimura RA,Bonow RO,Carabe...

see more →

Drugs  75 results see all →

Clinicaltrials.gov  182 results

Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment
https://clinicaltrials.gov/ct2/show/NCT05558605

Mar 3rd, 2023 - Heart Failure (HF) and valvular heart disease (VHD) are disproportionate problems in rural and remote Australia (RRA) relative to the rest of the country, due in part to an ageing rural population and to the frequency of rheumatic heart disease in...

Randomized Study for the Optimal Treatment of Symptomatic Patients With Low Gradient Severe Aortic Valve Stenosis and Preserved Left Ventricular Ejection Fraction
https://clinicaltrials.gov/ct2/show/NCT03667365

Mar 1st, 2023 - According to current European Recommendations on valvular heart disease (VHD), "classical" severe aortic stenosis (AS) is defined by an aortic valve area (AVA) ≤1 cm2 and indexed AVA ≤0.6 cm2/m2, a mean aortic pressure gradient (MAG) >40 mmHg, and...

Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level
https://clinicaltrials.gov/ct2/show/NCT05742503

Feb 24th, 2023 - Progestogen-only' contraceptives are presented as injections, implants, oral formulations, hormone-releasing intrauterine methods and emergency contraceptives. These substances could be used by females who are breastfeeding or have other contraind...

Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE
https://clinicaltrials.gov/ct2/show/NCT03488420

Feb 22nd, 2023 - This is an observational, prospective, multicenter, edoxaban Canadian registry of adults (≥18) diagnosed or confirmed with AF and/or AFL with VHD, within the last 12 months, according to local standard procedures and judged by the investigator to ...

Reperfusion Syndrome and Vasoplegic Syndrome in Liver Transplant Surgery
https://clinicaltrials.gov/ct2/show/NCT05658120

Feb 21st, 2023 - Introduction: At the time of the liver reperfusion, many inflammatory mediators coming from the liver graft to the systemic circulation produce a sudden load of cold and acidotic blood. At this stage of graft revascularization, it has been seen an...

see more →

News  274 results

Aortic Disease Clinical Practice Guidelines (ACC/AHA, 2022)
https://www.medscape.com/viewarticle/985190

Dec 9th, 2022 - Guidelines on the diagnosis and management of aortic disease were published in November 2022 by the American College of Cardiology (ACC) and the American Heart Association (AHA) in Circulation.[1,2,3,4,5] These recommendations replace the 2010 ACC...

ACC/AHA Issues Updated Guidance on Aortic Disease
https://www.medscape.com/viewarticle/983473

Nov 3rd, 2022 - The American College of Cardiology (ACC) and the American Heart Association (AHA) have published an updated guideline on the diagnosis and management of aortic disease, focusing on surgical intervention considerations, consistent imaging practices...

Management of antithrombotic medications in elective endoscopy
https://www.mdedge.com/gihepnews/article/258808/endoscopy/management-antithrombotic-medications-elective-endoscopy
Wenfei Wang, MD, Neil Sengupta, MD

Nov 1st, 2022 - Antithrombotic therapy is increasingly used to either reduce the risk of or treat thromboembolic episodes in patients with various medical conditions such as ischemic and valvular heart disease, atrial fibrillation (AF), cerebrovascular disease, p.

Apixaban outmatches rivaroxaban in patients with AFib and valvular heart disease
https://www.mdedge.com/internalmedicine/article/258703/cardiology/apixaban-outmatches-rivaroxaban-patients-afib-and
Will Pass

Oct 18th, 2022 - Apixaban offers greater protection than rivaroxaban against ischemic stroke, systemic embolism, and bleeding in patients with both atrial fibrillation (AFib) and valvular heart disease (VHD), a new study finds. Compared with rivaroxaban, apixaban c.

SPRINT BP Control Benefit Fizzles Out; Hot Flashes and CVD; Metformin for Afib?
https://www.medpagetoday.com/cardiology/prevention/101276

Oct 18th, 2022 - In a new policy statement, the American College of Cardiology endorsed more flexible hours and work arrangements so that cardiologists and trainees can have a better work-life balance. High-intensity care following heart failure (HF) hospitalizati...

see more →

Patient Education  23 results see all →